Vitrectomy Versus Suprachoroidal Steroid in Trematodal Granulomatous Uveitis
Key facts
- Who runs it
- Minia University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 20 Jan 2025
- Ended
- 25 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Vitrectomy
- Record updated
- 5 August 2025
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Children with history of fresh canal water exposure prior to the onset of uveitis
- Intermediate uveitis with CB granuloma detected by ultrasound biomicroscopy (UBM)
- Absence of clinical signs or work-up suggestive of any other cause of granulomatous intermediate uveitis
- Failure of medical treatment was defined as persistent or recurrent anterior (flare and cells >+1) and/or posterior segment inflammation (>Grade I vitritis) following oral steroids for 8-12 weeks as reported in previous literature
Who cannot take part
- previous ocular surgery
- known cause of granulomatous uveitis other than trematodal such as(Tuberculosis, sarcoidosis, Syphilis, toxoplasmosis, toxocariasis, Juvenile idiopathic arthritis)
- Co-existing ocular pathology that could influence the final visual acuity (VA)
- Evidence of ocular trauma
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Presumed trematode-induced granulomatous intermediate uveitis (PTIGIU) presents with vitritis and complicated cataract (active stage) which, if left untreated, progresses to tractional retinal detachment (TRD) from the vitreoretinal traction (cicatricial stage) and eventually cilliary body shut down and atrophia bulbi Accordingly, timely diagnosis of such patients during the active stage is essential for early proper management to avoid complications that might eventually result in blindness.
Read full original descriptionShow less
Many treatment modalities for the treatment of AC granulomas were reported, including various combinations of topical corticosteroids, systemic antiparasitic treatment, peribulbar anterior subtenon steroids injections and surgical granuloma excision. Resistant cases may be treated with oral prednisone starting at a daily dose of 1 mg/kg which is gradually tapered over 3-6 weeks . Therefore, many cases may develop steroid-related complications such as cataracts and glaucoma.
This study aims at comparing 6-month visual outcomes and complications after vitrectomy versus suprachoroidal triamcinolone acetonide (SCTA) injection in patient presented with cilliary body granuloma in Presumed trematode-induced granulomatous intermediate uveitis (PTIGIU).
The 2 groups in the trial
- Vitrectomy armExisting treatment, for comparison
Pars Plana vitrectomy and debulking of ciliary body granuloma
Treatment: Vitrectomy
- Suprachoroidal steroid injectionExisting treatment, for comparison
Suprachoroida steroid injection of triamcinolone acetonide for ciliary body granuloma.
Treatment: Vitrectomy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Outcomes of Vitrectomy Versus Suprachoroidal Steroid Injection in Cases of Presumed-trematode Induced Granulomatous Intermediate Uveitis
- Record updated
- 5 August 2025